ATE220905T1 - Benzo(b)thiophene derivaten zur verringerung der blutplätchenzahl - Google Patents

Benzo(b)thiophene derivaten zur verringerung der blutplätchenzahl

Info

Publication number
ATE220905T1
ATE220905T1 AT98306570T AT98306570T ATE220905T1 AT E220905 T1 ATE220905 T1 AT E220905T1 AT 98306570 T AT98306570 T AT 98306570T AT 98306570 T AT98306570 T AT 98306570T AT E220905 T1 ATE220905 T1 AT E220905T1
Authority
AT
Austria
Prior art keywords
benzo
platelet counts
thiophene derivatives
reducing platelet
reducing
Prior art date
Application number
AT98306570T
Other languages
English (en)
Inventor
Mark Chandrakant Lakshmanan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE220905T1 publication Critical patent/ATE220905T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
AT98306570T 1997-08-21 1998-08-18 Benzo(b)thiophene derivaten zur verringerung der blutplätchenzahl ATE220905T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5620397P 1997-08-21 1997-08-21

Publications (1)

Publication Number Publication Date
ATE220905T1 true ATE220905T1 (de) 2002-08-15

Family

ID=22002873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98306570T ATE220905T1 (de) 1997-08-21 1998-08-18 Benzo(b)thiophene derivaten zur verringerung der blutplätchenzahl

Country Status (22)

Country Link
US (1) US6103740A (de)
EP (1) EP0904783B1 (de)
JP (1) JP2001515015A (de)
KR (1) KR20010023075A (de)
CN (1) CN1275886A (de)
AT (1) ATE220905T1 (de)
AU (1) AU741882B2 (de)
BR (1) BR9811962A (de)
CA (1) CA2301806A1 (de)
DE (1) DE69806705T2 (de)
DK (1) DK0904783T3 (de)
EA (1) EA001582B1 (de)
ES (1) ES2181132T3 (de)
HR (1) HRP20000094A2 (de)
HU (1) HUP0002715A3 (de)
IL (1) IL134551A0 (de)
NO (1) NO20000750L (de)
NZ (1) NZ502842A (de)
PL (1) PL338700A1 (de)
PT (1) PT904783E (de)
TR (1) TR200000453T2 (de)
WO (1) WO1999008525A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624800D0 (en) * 1996-11-29 1997-01-15 Lilly Co Eli Methods of preventing breast cancer
US6353003B1 (en) 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein
JP2003509478A (ja) * 1999-09-21 2003-03-11 エモリー・ユニバーシティ 血小板関連障害を処置する方法および組成物
US20090092693A1 (en) * 2007-10-05 2009-04-09 Mady Attila Platelet manipulation to prevent and treat endovascular disease and its sequelae, to prevent and treat arrhythmias and to prevent malignancy
US8021854B2 (en) * 2007-10-05 2011-09-20 Attila Mady Method of treating vascular disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4447620A (en) * 1982-06-08 1984-05-08 The Upjohn Company Imidazolyl-substituted benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US4847276A (en) * 1988-09-06 1989-07-11 Merrell Dow Pharmaceuticals Inc. Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione
JPH0517357A (ja) * 1991-07-05 1993-01-26 Nissan Chem Ind Ltd 血小板減少療法剤
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5424334A (en) * 1991-12-19 1995-06-13 G. D. Searle & Co. Peptide mimetic compounds useful as platelet aggregation inhibitors
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
US6025373A (en) * 1997-04-22 2000-02-15 Eli Lilly And Company Methods for reducing fibrinogen

Also Published As

Publication number Publication date
NO20000750L (no) 2000-04-13
IL134551A0 (en) 2001-04-30
DE69806705T2 (de) 2003-03-20
US6103740A (en) 2000-08-15
DE69806705D1 (de) 2002-08-29
EP0904783B1 (de) 2002-07-24
ES2181132T3 (es) 2003-02-16
EA200000243A1 (ru) 2000-10-30
TR200000453T2 (tr) 2000-08-21
AU8830698A (en) 1999-03-08
DK0904783T3 (da) 2002-09-02
AU741882B2 (en) 2001-12-13
EP0904783A1 (de) 1999-03-31
WO1999008525A1 (en) 1999-02-25
HUP0002715A2 (hu) 2001-06-28
HUP0002715A3 (en) 2002-12-28
BR9811962A (pt) 2000-08-15
KR20010023075A (ko) 2001-03-26
PT904783E (pt) 2002-10-31
HRP20000094A2 (en) 2000-08-31
NO20000750D0 (no) 2000-02-15
CN1275886A (zh) 2000-12-06
NZ502842A (en) 2001-11-30
CA2301806A1 (en) 1999-02-25
EA001582B1 (ru) 2001-06-25
JP2001515015A (ja) 2001-09-18
PL338700A1 (en) 2000-11-20

Similar Documents

Publication Publication Date Title
DE69432243D1 (de) 2-Phenyl-3-Aroylbenzothiophene zur Behandlung der menstruellen Symptome
EP0897721A3 (de) Benzo(b)thiophene Derivativen zur Hemmung von durch die Verrabreichung GnRH oder GnRH-Agonisten verursachten unheilvollen Nebenwirkungen
DK0605193T3 (da) Anvendelse af benzothiophener til behandling af hypercholesterolæmi
CA2315050A1 (en) Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof
IL111284A (en) 2-phenyl-3-aroylbenzothiophenes for use as medicaments for inhibiting endometriosis
DK0664126T3 (da) Hæmning af trombin
CA2266107A1 (en) Aralkyl and aralkylidene heterocyclic lactams and imides
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
IL111290A (en) Uses of 2-phenyl-3-aroylbenzothiophenes in the preparation of medicaments useful in the treatment of peri-menopausal syndrome
DE69433578D1 (de) Hemmung der Endprodukte fortgeschrittener Glykolisierung
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
DK0659417T3 (da) Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
PT992509E (pt) Novos derivados macrolidos
DE69806705D1 (de) Benzo(b)thiophene Derivaten zur Verringerung der Blutplätchenzahl
NZ335631A (en) Antipsychotic (neuroleptic) piperidine derivatives
DE69302035D1 (de) Pharmazeutische Zusammensetzung zur Hemmung der Thrombocytenaggregation
DE69102379D1 (de) Pharmazeutische Zusammensetzung zur Verhinderung der Plättchenaggregation.
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
NZ230854A (en) 1,4 dihydropyridine derivatives, intermediate compound and pharmaceutical compositions
YU2397A (en) 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee